ES514896A0 - Procedimiento para la preparacion de una suspension hidroalcoholica. - Google Patents

Procedimiento para la preparacion de una suspension hidroalcoholica.

Info

Publication number
ES514896A0
ES514896A0 ES514896A ES514896A ES514896A0 ES 514896 A0 ES514896 A0 ES 514896A0 ES 514896 A ES514896 A ES 514896A ES 514896 A ES514896 A ES 514896A ES 514896 A0 ES514896 A0 ES 514896A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
suspension
hydroalcoholic suspension
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES514896A
Other languages
English (en)
Other versions
ES8400029A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme IA Corp
Merck Sharp and Dohme Corp
Original Assignee
Merck Sharp and Dohme IA Corp
Merck Sharp and Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme IA Corp, Merck Sharp and Dohme Corp filed Critical Merck Sharp and Dohme IA Corp
Publication of ES514896A0 publication Critical patent/ES514896A0/es
Publication of ES8400029A1 publication Critical patent/ES8400029A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
ES514896A 1981-08-12 1982-08-10 Procedimiento para la preparacion de una suspension hidroalcoholica. Expired ES8400029A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/292,111 US4377568A (en) 1981-08-12 1981-08-12 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same

Publications (2)

Publication Number Publication Date
ES514896A0 true ES514896A0 (es) 1983-10-16
ES8400029A1 ES8400029A1 (es) 1983-10-16

Family

ID=23123272

Family Applications (1)

Application Number Title Priority Date Filing Date
ES514896A Expired ES8400029A1 (es) 1981-08-12 1982-08-10 Procedimiento para la preparacion de una suspension hidroalcoholica.

Country Status (13)

Country Link
US (1) US4377568A (es)
EP (1) EP0072021B1 (es)
JP (1) JPS5839626A (es)
AT (1) ATE29107T1 (es)
AU (1) AU551761B2 (es)
CA (1) CA1199869A (es)
DE (1) DE3277061D1 (es)
DK (1) DK360082A (es)
ES (1) ES8400029A1 (es)
GR (1) GR76248B (es)
NZ (1) NZ201470A (es)
PT (1) PT75382B (es)
ZA (1) ZA825811B (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462839A (en) * 1983-06-16 1984-07-31 Fmc Corporation Enteric coating for pharmaceutical dosage forms
US4705804A (en) * 1985-05-06 1987-11-10 Technology Unlimited, Inc. Diarrheal antitoxin
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
FI101344B1 (fi) † 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US6224911B1 (en) 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
JP3350054B2 (ja) * 1994-07-08 2002-11-25 アストラゼネカ・アクチエボラーグ 複数単位の錠剤化された剤形▲ｉ▼
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
US6559158B1 (en) 1997-11-03 2003-05-06 Ur Labs, Inc. Use of methylnaltrexone and related compounds to treat chronic opioid use side affects
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR101476574B1 (ko) 1999-10-29 2014-12-24 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US6423376B1 (en) 2000-04-06 2002-07-23 Air Products And Chemicals, Inc. Tartaric acid diesters as biodegradable surfactants
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
WO2002098422A1 (en) * 2001-06-05 2002-12-12 University Of Chicago Use of methylnaltrexone to treat immune suppression
EP1638607A1 (en) * 2003-04-08 2006-03-29 Progenics Pharmaceuticals, Inc. Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
CA2521369A1 (en) * 2003-04-08 2004-10-28 Progenics Pharmaceuticals, Inc. The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
PL2368553T3 (pl) * 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
EP1845989A1 (en) * 2005-01-20 2007-10-24 Progenics Pharmaceuticals, Inc. Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction
MX2007010833A (es) * 2005-03-07 2009-02-17 Univ Chicago Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) * 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
US20080194611A1 (en) * 2005-06-03 2008-08-14 Alverdy John C Modulation of Cell Barrier Dysfunction
EP2068840A2 (en) * 2006-07-21 2009-06-17 LAB International SRL Hydrophobic abuse deterrent delivery system
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
ES2540551T3 (es) * 2007-03-29 2015-07-10 Wyeth Llc Antagonistas de receptores opioides periféricos y usos de los mismos
AU2008233129B2 (en) * 2007-03-29 2014-03-20 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
CN101959892B (zh) * 2008-02-06 2014-01-08 普罗热尼奇制药公司 (r),(r)-2,2’-二-甲基纳曲酮的制备和用途
JP5647098B2 (ja) 2008-03-21 2014-12-24 ザ ユニヴァーシティー オヴ シカゴ オピオイド拮抗薬とｍＴＯＲ阻害薬を用いた治療
WO2010002576A1 (en) 2008-07-01 2010-01-07 University Of Chicago Particles containing an opioid receptor antagonist and methods of use
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
EP3718404A1 (en) 2014-10-17 2020-10-07 Salix Pharmaceuticals, Inc. Use of methylnaltrexone to attenuate tumor progession
JP6855469B2 (ja) 2015-10-16 2021-04-07 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 消化器標的療法のための処方物を調製するための工程

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449489A (en) * 1965-10-21 1969-06-10 William E Gaunt Pharmaceutical compositions and their preparation
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
FR2118883A1 (en) * 1970-12-26 1972-08-04 Green Cross Corp Enteric coating of hard capsules - after pre-sealing with aq org solvent mixtures
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
JPS5598120A (en) * 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating
DE2926633C2 (de) * 1979-07-02 1982-11-25 Kurt Heinz Prof. Dr. Bauer Verfahren für die Filmbeschichtung eines teilchenförmigen, festen Arzneimittels und Emulsionen zur Durchführung des Verfahrens

Also Published As

Publication number Publication date
DK360082A (da) 1983-02-13
AU8706882A (en) 1983-05-12
US4377568A (en) 1983-03-22
PT75382A (en) 1982-09-01
ATE29107T1 (de) 1987-09-15
EP0072021A2 (en) 1983-02-16
AU551761B2 (en) 1986-05-08
JPS5839626A (ja) 1983-03-08
EP0072021A3 (en) 1984-08-22
ZA825811B (en) 1984-03-28
PT75382B (en) 1985-11-15
EP0072021B1 (en) 1987-08-26
CA1199869A (en) 1986-01-28
NZ201470A (en) 1985-03-20
GR76248B (es) 1984-08-04
DE3277061D1 (en) 1987-10-01
ES8400029A1 (es) 1983-10-16

Similar Documents

Publication Publication Date Title
ES514896A0 (es) Procedimiento para la preparacion de una suspension hidroalcoholica.
FR2504408B1 (fr) Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
ES8707110A1 (es) Un procedimiento para preparar una composicion farmaceutica oral, de accion prolongada, en forma de dosificacion unitaria solida.
BE901359A (fr) Composition pharmaceutique a absorption reglee.
NO834052L (no) Enterisk belegg for farmasoeytiske doseringsformer
FR2326447A1 (fr) Dispersion stable de particules de resine de polyfluorocarbure chargees positivement et procede pour sa preparation
SG33388G (en) Salts of 2(2,6-dichloroanilino) phenylacetic acid and their production
AU2198083A (en) Aqueous dispersion of plasticised polymer particles
BR8205913A (pt) Composicao para o revestimento de uma substancia biologicamente ativa e granulados destinados a serem administrados pro via oral a animais
PT78275B (fr) Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant
BE889604A (fr) Procede de preparation d'acetaldehyde et d'ethanol
BE888867A (fr) Procede de preparation de particules de polymere spheriques et particules ainsi obtenues
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
IT8321684A0 (it) Derivati di piridazinoni impiegabili come sostanze medicinali e procedimenti per laloro fabbricazione.
MX158979A (es) Proceso mejorado para la obtencion de particulas esfericas y porosas de una resina vinilica
PT74092A (en) Process for the preparation of clavulanic acid derivatives and their use
ZA74404B (en) 4,8-dimethoxy-furo(3',2'-f)benzoxazol-2-yl acethydroxamic acid,its process of preparation and its therapeutic application
SE8603559L (sv) Vattenuppslamning av forkolade emnen, tillverkningsforfarande och tillverkningsutrustning for detta
PT76389B (en) Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect
PT76952A (en) Process for the preparation of racemic and optically active eburnane deriatives and pharmaceutical compositions conaining them
PT76951A (en) Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them
GB2074600B (en) Amino-substituted 2-cumaryl-(3')-chromenylium salts and methods of producing same
ATE51149T1 (de) Therapeutische anwendung eines indandionderivats und pharmazeutische zusammensetzungen zu ihrer verwendung.
PT77752B (fr) Procede de preparation de derives benzylideniques alkyles et de compositions pharmaceutiques les contenant
PT74141A (fr) Procede de preparation de derives d'indoloquinolizine et de compositions pharmaceutiques les contenant